Embryonic Stem Cell Research
Supporting Innovation:
Because the federal government has severely limited this type of stem cell research to a small of number of what we now know are unsuitable lines of embryonic stem cells, the states have started to take the lead in this exciting research. Much is at stake: staying at the cutting edge of biomedical discoveries; relieving suffering from painful, debilitating, and terminal conditions; reversing the brain drain of researchers, enhancing economic development, increasing civic pride, and the opportunity to strengthen in every way our world-class hospitals and research facilities. A few states — notably New Jersey, Wisconsin and Illinois — are rushing to catch up with California in encouraging stem cell research, with an eye on the prestige and economic benefits that could result. At the moment, Pennsylvania is nowhere.
I have been and will continue to be a leader on this issue. I have introduced legislation authorizing embryonic stem cell research in successive sessions. In September of 2005, I held a hearing and arranged a tour for legislators at the University of Pennsylvania. Although there were opponents in attendance, I was very pleased with the positive response from most lawmakers. Gov. Rendell enthusiastically supports my initiative. I look forward to success; I will not quit until we have won this battle.
Life Sciences Caucus:
I serve on the Pennsylvania House Life Sciences Caucus. The Caucus focuses on biotechnology and the life sciences in Pennsylvania and will address issues of importance to the biotechnology and life sciences community, including both research and business growth.
Pennsylvania is a world-leading location for the life sciences with more than 2,000 companies directly related to the industry, employing nearly 84,000 Pennsylvanians, and approximately twice this in indirect employment from industries that support the life sciences. The therapies, devices, diagnostics and vaccines that companies in Pennsylvania are researching and developing will provide relief and cures for people globally who suffer from debilitating, painful, or terminal conditions.
Early in 2006, Governor Rendell announced a biomedical research funding initiative, which I strongly support.